CD4 and infection: An earlier study conducted in patients with (hematologic) malignancies infected with SARS-CoV-2 wild-type demonstrated that the presence of SARS-CoV-2–specific CD4+ T cells in the weeks after infection is associated with a reduced time to viral clearance, using a similar cut-off of 30 days [5].